Annals of Long Term Care

First Report®

First Report®

ISSN: 1524-7929 VOLUME: 18 PUBLICATION DATE: Jun 15 2010
Issue Number: 
Volume 18-Issue 6-June 2010

American Geriatrics Society 2010 Annual Scientific Meeting
Orlando, FL; May 12-15, 2010

Managing Atrial Fibrillation in the Older Patient

First Report®

ISSN: 1524-7929 VOLUME: 18 PUBLICATION DATE: May 20 2010
Issue Number: 
Volume 18-Issue 5-May 2010

American Association for Geriatric Psychiatry 2010 Annual Meeting
Savannah, GA; March 5-8, 2010

Poster

Effects of Rivastigmine Transdermal Patch on Cognitive Ability in Patients with Mild-to-Moderately Severe AD

Savannah, GA—In their study examining the specific effects of rivastigmine on individual Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) items and cognitive domain scores, George T. Grossberg, MD, St. Louis University School of Medicine, St. Louis, MO, and colleagues found that the rivastigmine patch is associated with improved co

First Report®

ISSN: 1524-7929 VOLUME: 18 PUBLICATION DATE: Apr 01 2010
Issue Number: 
Volume 18 - Issue 4 - April 2010

American Medical Directors Association Long-Term Care Medicine 2010
Long Beach, CA; March 11-14, 2010

Poster

The Effect of Medicare Part D on Patients with Parkinson’s Disease
Long Beach, CA--It is estimated that 3% of the U.S. population age 65 and over are affected by Parkinson's disease (PD). Many patients with PD are enrolled in Medicare Part D (MPD), a prescription drug coverage program for seniors established by the Medicare Modernization Act of 2003. The Standard Benefit of Part D includes a gap in coverage, commonly known as the doughnut hole (DH). The

American Epilepsy Society 63rd Annual Meeting

ISSN: 1524-7929 VOLUME: 18 PUBLICATION DATE: Mar 01 2010
Issue Number: 
Volume 18 - Issue 3 - March 2010

Poster

Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures

Boston, MA—The purpose of this study, presented as a poster at the annual AES meeting, was to examine the long-term safety of lacosamide (LCM) for partial-onset seizures based on all available data from Phase II-III double-blind and open-label extension trials. William Rosenfeld, MD, of the Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, and colleagues found that long-term LCM treatment was generally well tolerated in their analysis of 1327 patients exposed to LCM

First Report®

ISSN: 1524-7929 VOLUME: 18 PUBLICATION DATE: Feb 01 2010
Issue Number: 
Volume 18 - Issue 2 - February 2010

Infectious Diseases Society of America 47th Annual Meeting
October 29-November 1, 2009; Philadelphia, PA

POSTER

Clinical Experience with Daptomycin for the Treatment of Patients with Bacteremic Skin and Skin-Structure Infections

Philadelphia, PA—Data from the Cubicin® Outcomes Registry and Experience (CORE) 2005-2008, a retrospective, multicenter, observational chart review to assess characteristics and clinical outcome of patients receiving daptomycin, support the use of daptomycin for skin and skin structure infections (SSSI) bacteremia (BSI). Researche

First Report®

ISSN: 1524-7929 VOLUME: 17 PUBLICATION DATE: Dec 01 2009
Issue Number: 
Volume 17 - Issue 12 - December 2009



American Society of Consultant Pharmacists 40th Annual Meeting
Anaheim, CA; November 18-20, 2009

__________________

Functional Communication in Alzheimer’s Disease in LTC

Anaheim, CA—Alzheimer’s disease (AD) can profoundly affect communication skills of frail elderly residents in LTC settings. Dr. Richard Stefanacci, Director of the Institute for Geriatric Studies at the Mayes College of Healthcare Business & Policy, University of the Sciences, Philadelphia, PA, and medical director of NewCourtland LIFE, spoke at the American Society of Consultant Pharm

First Report

ISSN: 1524-7929 VOLUME: 17 PUBLICATION DATE: Nov 09 2009
Issue Number: 
2 Nov 2009

American Academy of Family Physicians 2009 Scientific Assembly

October 14-17, 2009; Boston, MA

Screening and Preventive Care in the Elderly

Boston, MA—Aubrey L. Knight, MD, FAAFP, presented a session at the American Academy of Family Physicians (AAFP) meeting on screening and preventive care in the elderly. Challenges for clinicians include the fact that most trials exclude patients over age 75, data from trials are not necessarily applicable to individual patients, and trials do not address how individual characteristics affect the benefit versus

First Report®: 31st Annual Meeting of the American Society for Bone and Mineral Research Denver, CO; September 11-15, 2009

ISSN: 1524-7929 VOLUME: 17 PUBLICATION DATE: Oct 01 2009
Issue Number: 
Volume 17 - Issue 10 - October 2009

Decreased Serum Vitamin B12 Concentration is Associated With Greater Fall Risk Among Older Disabled Women: The Women’s Health and Aging Study

Denver, CO—Robert McLean, DSc, Hebrew SeniorLife Institute for Aging Research and Harvard Medical School, Boston, MA, and colleagues examined the associations of serum concentrations of folate, vitamin B12, methylmalonic acid (MMA) and homocysteine with the risk of falling among older disabled women participating in the Women’s Health and Aging Study. Results presented at the ASBMR annual meeting suggest that low vitamin B12 status may

First Report®

ISSN: 1524-7929 VOLUME: 17 PUBLICATION DATE: Sep 01 2009
Issue Number: 
Volume 17 - Issue 9 - September 2009



Digestive Disease Week 2009
Chicago, IL; May 30-June 4, 2009

______________________________

Elderly Patients Present with More Advanced Appendicitis

Chicago, IL—Investigators led by Rebecca J. Rose, MD, of the Department of Surgery, State University of New York at Buffalo, recently conducted a retrospective study to ascertain what factors may account for the delayed presentation and more advanced disease states of elderly patients with acute appendicitis and presented their results at the DDW meeting. They conducted a 5-year retrospective chart review fro

First Report®

ISSN: 1524-7929 VOLUME: 17 PUBLICATION DATE: Aug 01 2009
Issue Number: 
Volume 17 - Issue 8 - August 2009



2009 National Association Directors of Nursing Administration/Long Term Care National Conference

July 11-15, 2009; Phoenix, AZ



POSTER

The Effects of Donepezil on Patients with Mild to Severe Alzheimer’s Disease Residing in ALFs

Phoenix, AZ—In their study assessing the safety and efficacy of donepezil in patients with Alzheimer’s disease (AD) residing exclusively in assisted living facilities (ALFs), Adam Rosenblatt, MD, Johns Hopkins School of Medicine, Baltimore, MD, and colleagues concluded that donepezil treatment significantly improved







REVIEW OUR OTHER
HEALTHCARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Clinical Geriatrics
  • Podiatry Today
  • Skin & Aging
  • OWM

Real Time Web Analytics